Anna Eshoo: “We seriously disagree about the wisdom of the current effort, and I hope the majority will reconsider its plans.”

Spectrum is the gold in the 21st century. Nothing moves without spectrum.

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

The PBM Accountability Act will finally shed a light on the opaque drug pricing system.

I want to ask you if you will consider STAs and if you will commit to providing the public transparency that is really due because this is a huge issue?